Publication | Open Access
Activities of Moxifloxacin Alone and in Combination with Other Antimicrobial Agents against Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Infection in BALB/c Mice
48
Citations
12
References
2002
Year
Antibiotic AdjuvantImmunologyPharmacotherapyAntimicrobial ChemotherapyBalb/c MiceDrug ResistanceMultidrug-resistant TuberculosisMedicinal ChemistryMycobacterium Tuberculosis ResistantOther Antimicrobial AgentsAntimicrobial TherapyInfection ControlAntibacterial MechanismsAntimicrobial ResistanceHealth SciencesPulmonary TuberculosisMoxifloxacin AlonePara-aminosalicylic AcidTuberculosisAntibacterial AgentAntimicrobial PharmacokineticsBacterial ResistancePharmacologyClinical MicrobiologyAntibioticsMicrobiologyMedicineDrug Discovery
The activity of moxifloxacin was enhanced by the addition of ethionamide but not by that of cycloserine, thiacetazone, capreomycin, para-aminosalicylic acid, or linezolid in BALB/c mice infected with a strain of Mycobacterium tuberculosis resistant to isoniazid, rifampin, and six other drugs. These observations are important for the therapy of multidrug-resistant tuberculosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1